Skip to main content

Lab+Life Scientist Aug/Sep 2023

Page 18

clinical diagnostics

Spinal fluid test can

detect Lewy body disease early Researchers from Lund University have shown that Lewy body disease — the second most common neurodegenerative disease after Alzheimer’s disease — can be detected before symptoms appear, using a spinal fluid test. They also demonstrated that reduced sense of smell is strongly linked to Lewy body disease even before other clear symptoms have developed. age with a smell test and then proceed with testing spinal fluid if one wants to detect Lewy body disease early, according to Hansson. “Several drugs targeted at Lewy bodies are currently being developed, with the hope of slowing down the disease,” Hansson said. “Most likely, this type of medication has the best chance of being effective if administered early in the course of the disease. If symptom-free individuals with reduced sense of smell were identified, and the test for Lewy iStock.com/Marcin Klapczynski

bodies was positive, they could participate in drug trials aimed at developing new medications that can halt the disease early.” In a second publication, also in Nature Medicine, the research group studied over 800 individuals with cognitive difficulties and found that around one-fourth of them had a test result

L

ewy body disease is an umbrella term

for Parkinson’s disease and Lewy body dementia. When movement difficulties are more dominant, the disease is called Parkinson’s disease; when cognitive impairments are dominant, the term Lewy body dementia is used. “Lewy body disease is caused by the misfolding

indicative of Lewy body disease. Approximately Hansson’s research group recently completed

50% of those with Lewy body disease also had

a large study involving over 1100 individuals,

accumulation of the proteins amyloid and tau,

none of whom initially showed any cognitive

which are associated with Alzheimer’s disease. For

impairments or motor difficulties. However, it

individuals who had both amyloid and tau, as well

turned out that nearly 10% had Lewy bodies in

as Lewy bodies, the disease progressed faster. This

their brains according to the spinal fluid test. Their

suggests that these brain changes interact, which

results, published in the journal Nature Medicine,

is of great clinical importance for predicting the

thus showed that it is possible to detect Lewy body

patient’s prognosis.

disease even before the first symptoms appear.

Hansson hopes that, just like for Alzheimer’s

”Despite the participants not having any

disease, it will be possible to develop a blood test

cognitive or neurological problems at the beginning

for Lewy body disease. One of the challenges with

of the alpha-synuclein protein in the brain,” said

of the study, we observed that those with Lewy bodies

this is that the concentration of proteins originating

Oskar Hansson, Professor of Neurology at Lund

in the brain subsequently experienced a decline in

from the brain is often 100–1000 times lower in

University. “When this happens, the protein clumps

their cognitive functions over time,” Hansson said.

the blood than in the spinal fluid, which can make

together and forms what are called Lewy bodies,

“They were also the ones who developed Parkinson’s

it difficult to detect Lewy body changes. In the

which damage the nerve cells.”

disease or Lewy body dementia in the coming years.”

meantime, the spinal fluid test is a big step forward

Until very recently, it was not possible to

A second finding was that Lewy bodies are

determine with certainty whether a person with

strongly associated with a reduced sense of smell

“I believe that this test for Lewy body disease

movement difficulties or cognitive impairments

even before other symptoms have developed.

will start being used relatively soon to improve the

had Lewy bodies in the brain until after their death.

The sense of smell also deteriorates as the disease

diagnostic and prognostic work-up in clinics that

But now, with a spinal fluid test, it is possible to see

progresses. The correlation is so clear that it could

take care of individuals with movement disorders

if the person has the misfolded protein.

be justified to screen individuals over 60 years of

and cognitive symptoms,” Hansson said.

18 | LAB+LIFE SCIENTIST - Aug/Sep 2023

for early diagnosis.

www.LabOnline.com.au | www.LifeScientist.com.au


Turn static files into dynamic content formats.

Create a flipbook
Lab+Life Scientist Aug/Sep 2023 by Westwick-Farrow Media - Issuu